{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:24:34Z","timestamp":1772069074629,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s13577-018-00225-1","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T21:02:14Z","timestamp":1548709334000},"page":"160-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3"],"prefix":"10.1007","volume":"32","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Ping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"225_CR1","first-page":"7845","volume":"17","author":"WJ Wu","year":"2018","unstructured":"Wu WJ, Shen Y, Sui J, et al. Integrated analysis of long noncoding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database. Mol Med Rep. 2018;17:7845\u201358.","journal-title":"Mol Med Rep"},{"key":"225_CR2","first-page":"389","volume":"14","author":"ZO Amarin","year":"2008","unstructured":"Amarin ZO, Badria LF, Obeidat BR. Attitudes and beliefs about cervical smear testing in ever-married Jordanian women. East Mediterr Health J. 2008;14:389\u201397.","journal-title":"East Mediterr Health J"},{"key":"225_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.21147\/j.issn.1000-9604.2017.06.01","volume":"29","author":"B Song","year":"2017","unstructured":"Song B, Ding C, Chen W, Sun H, Zhang M, Chen W. Incidence and mortality of cervical cancer in China, 2013. Chin J Cancer Res. 2017;29:471\u201376.","journal-title":"Chin J Cancer Res"},{"key":"225_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4014\/jmb.1511.11010","volume":"26","author":"HB Bang","year":"2016","unstructured":"Bang HB, Lee YH, Lee YJ, Jeong KJ. High-level production of human papillomavirus (HPV) type 16 L1 in Escherichia coli. J Microbiol Biotechnol. 2016;26:356\u201363.","journal-title":"J Microbiol Biotechnol"},{"key":"225_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s10552-016-0816-4","volume":"27","author":"LS Murdiyarso","year":"2016","unstructured":"Murdiyarso LS, Kartawinata M, Jenie I, et al. Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta. Cancer Causes Control. 2016;27:1371\u201379.","journal-title":"Cancer Causes Control"},{"key":"225_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.vaccine.2015.12.011","volume":"34","author":"M Fakhreldin","year":"2016","unstructured":"Fakhreldin M, Elmasry K. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): a retrospective study in a tertiary hospital in United Arab Emirates (UAE). Vaccine. 2016;34:823\u201330.","journal-title":"Vaccine"},{"key":"225_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/15476286.2016.1182279","volume":"13","author":"W Rennie","year":"2016","unstructured":"Rennie W, Kanoria S, Liu C, et al. STarMirDB: a database of microRNA binding sites. RNA Biol. 2016;13:554\u201360.","journal-title":"RNA Biol"},{"key":"225_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11102-017-0805-y","volume":"20","author":"F Garbicz","year":"2017","unstructured":"Garbicz F, Mehlich D, Rak B, et al. Increased expression of the microRNA 106b\u2009~\u200925 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke\u2019s cell morphology. Pituitary. 2017;20:450\u201363.","journal-title":"Pituitary"},{"key":"225_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1476-4598-13-51","volume":"13","author":"X Lyu","year":"2014","unstructured":"Lyu X, Fang W, Cai L, et al. TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer. 2014;13:51.","journal-title":"Mol Cancer"},{"key":"225_CR10","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.3748\/wjg.v19.i24.3770","volume":"19","author":"J Zou","year":"2013","unstructured":"Zou J, Mi L, Yu XF, Dong J. Interaction of 14-3-3sigma with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol. 2013;19:3770\u201380.","journal-title":"World J Gastroenterol"},{"key":"225_CR11","doi-asserted-by":"publisher","first-page":"e87780","DOI":"10.1371\/journal.pone.0087780","volume":"9","author":"W Zhu","year":"2014","unstructured":"Zhu W, He J, Chen D, et al. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One. 2014;9:e87780.","journal-title":"PLoS One"},{"key":"225_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.18632\/oncotarget.4399","volume":"7","author":"PP Piccaluga","year":"2016","unstructured":"Piccaluga PP, Navari M, De Falco G, et al. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget. 2016;7:224\u201340.","journal-title":"Oncotarget"},{"key":"225_CR13","doi-asserted-by":"publisher","first-page":"12273","DOI":"10.1007\/s13277-016-5097-8","volume":"37","author":"AN Zekri","year":"2016","unstructured":"Zekri AN, Youssef AS, El-Desouky ED, et al. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Tumour Biol. 2016;37:12273\u201386.","journal-title":"Tumour Biol"},{"key":"225_CR14","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1007\/s13277-015-4248-7","volume":"37","author":"S Sharma","year":"2016","unstructured":"Sharma S, Hussain S, Soni K, et al. Novel microRNA signatures in HPV-mediated cervical carcinogenesis in Indian women. Tumour Biol. 2016;37:4585\u201395.","journal-title":"Tumour Biol"},{"key":"225_CR15","doi-asserted-by":"publisher","first-page":"81512","DOI":"10.18632\/oncotarget.13130","volume":"7","author":"H Namba-Fukuyo","year":"2016","unstructured":"Namba-Fukuyo H, Funata S, Matsusaka K, et al. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein\u2013Barr virus infection. Oncotarget. 2016;7:81512\u201326.","journal-title":"Oncotarget"},{"key":"225_CR16","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.3748\/wjg.v22.i22.5183","volume":"22","author":"CS Yen","year":"2016","unstructured":"Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2016;22:5183\u201392.","journal-title":"World J Gastroenterol"},{"key":"225_CR17","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.18632\/oncotarget.3085","volume":"6","author":"K Ohta","year":"2015","unstructured":"Ohta K, Hoshino H, Wang J, et al. MicroRNA-93 activates c-Met\/PI3K\/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget. 2015;6:3211\u201324.","journal-title":"Oncotarget"},{"key":"225_CR18","doi-asserted-by":"publisher","first-page":"e0164701","DOI":"10.1371\/journal.pone.0164701","volume":"11","author":"D Gao","year":"2016","unstructured":"Gao D, Zhang Y, Zhu M, Liu S, Wang X. miRNA expression profiles of HPV-infected patients with cervical cancer in the Uyghur population in China. PLoS One. 2016;11:e0164701.","journal-title":"PLoS One"},{"key":"225_CR19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s10620-017-4579-x","volume":"62","author":"H Cui","year":"2017","unstructured":"Cui H, Zhang S, Zhou H, Guo L. Direct downregulation of B-cell translocation gene 3 by microRNA-93 is required for desensitizing esophageal cancer to radiotherapy. Dig Dis Sci. 2017;62:1995\u20132003.","journal-title":"Dig Dis Sci"},{"key":"225_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13046-017-0520-6","volume":"36","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Sun F, Dong P, et al. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5\/BTG3 signaling. J Exp Clin Cancer Res. 2017;36:48.","journal-title":"J Exp Clin Cancer Res"},{"key":"225_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"A World Medical","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"key":"225_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/JCM.00896-09","volume":"48","author":"A Sargent","year":"2010","unstructured":"Sargent A, Bailey A, Turner A, et al. Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol. 2010;48:554\u20138.","journal-title":"J Clin Microbiol"},{"key":"225_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1530\/REP-09-0341","volume":"139","author":"M Jovanovic","year":"2010","unstructured":"Jovanovic M, Stefanoska I, Radojcic L, Vicovac L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction. 2010;139:789\u201398.","journal-title":"Reproduction"},{"key":"225_CR24","doi-asserted-by":"publisher","first-page":"16890","DOI":"10.1038\/srep16890","volume":"5","author":"T Sathyapalan","year":"2015","unstructured":"Sathyapalan T, David R, Gooderham NJ, Atkin SL. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep. 2015;5:16890.","journal-title":"Sci Rep"},{"key":"225_CR25","doi-asserted-by":"publisher","first-page":"e0165776","DOI":"10.1371\/journal.pone.0165776","volume":"11","author":"S Chen","year":"2016","unstructured":"Chen S, Chen X, Sun KX, et al. MicroRNA-93 promotes epithelial\u2013mesenchymal transition of endometrial carcinoma cells. PLoS One. 2016;11:e0165776.","journal-title":"PLoS One"},{"key":"225_CR26","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.7314\/APJCP.2013.14.3.2113","volume":"14","author":"L Wang","year":"2013","unstructured":"Wang L, Wang Q, Li HL, Han LY. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2\/MMP9 in human cervical carcinoma\u2013relationship with prognosis. Asian Pac J Cancer Prev. 2013;14:2113\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"225_CR27","first-page":"3432","volume":"94","author":"X Zhao","year":"2014","unstructured":"Zhao X, Cui Y, Jiang S, et al. Comparative study of HR HPV E6\/E7 mRNA and HR-HPV DNA in cervical cancer screening. Zhonghua Yi Xue Za Zhi. 2014;94:3432\u20135.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"225_CR28","first-page":"3195","volume":"36","author":"A Stiasny","year":"2016","unstructured":"Stiasny A, Kuhn C, Mayr D, et al. Immunohistochemical evaluation of E6\/E7 HPV oncoproteins staining in cervical cancer. Anticancer Res. 2016;36:3195\u20138.","journal-title":"Anticancer Res"},{"key":"225_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju241","volume":"106","author":"Q Tian","year":"2014","unstructured":"Tian Q, Li Y, Wang F, et al. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus\u2013positive women. J Natl Cancer Inst. 2014;106:1\u20138.","journal-title":"J Natl Cancer Inst."},{"key":"225_CR30","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gks1466","volume":"41","author":"T Hassan","year":"2013","unstructured":"Hassan T, Smith SG, Gaughan K, et al. Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique. Nucleic Acids Res. 2013;41:e71.","journal-title":"Nucleic Acids Res"},{"key":"225_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1349-7006.2008.01030.x","volume":"100","author":"M Yoneda","year":"2009","unstructured":"Yoneda M, Suzuki T, Nakamura T, et al. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 2009;100:225\u201332.","journal-title":"Cancer Sci"},{"key":"225_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2013.06.062","volume":"437","author":"X Chen","year":"2013","unstructured":"Chen X, Chen G, Cao X, Zhou Y, Yang T, Wei S. Downregulation of BTG3 in non-small cell lung cancer. Biochem Biophys Res Commun. 2013;437:173\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"225_CR33","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.18632\/oncotarget.3734","volume":"6","author":"WF Gou","year":"2015","unstructured":"Gou WF, Yang XF, Shen DF, et al. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy. Oncotarget. 2015;6:19841\u201367.","journal-title":"Oncotarget"},{"key":"225_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/carcin\/bgp042","volume":"30","author":"S Majid","year":"2009","unstructured":"Majid S, Dar AA, Ahmad AE, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009;30:662\u201370.","journal-title":"Carcinogenesis"},{"key":"225_CR35","first-page":"173","volume":"14","author":"J Yu","year":"2008","unstructured":"Yu J, Zhang Y, Qi Z, Kurtycz D, Vacano G, Patterson D. Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells. Gene Expr. 2008;14:173\u201382.","journal-title":"Gene Expr"},{"key":"225_CR36","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1038\/sj.emboj.7601825","volume":"26","author":"YH Ou","year":"2007","unstructured":"Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J. 2007;26:3968\u201380.","journal-title":"EMBO J"},{"key":"225_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/jog.13027","volume":"42","author":"J Zhang","year":"2016","unstructured":"Zhang J, Wang F, Xu J, Wang X, Ye F, Xie X. Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1. J Obstet Gynaecol Res. 2016;42:1168\u201379.","journal-title":"J Obstet Gynaecol Res"},{"key":"225_CR38","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3892\/ijo.2016.3761","volume":"49","author":"S Shyamasundar","year":"2016","unstructured":"Shyamasundar S, Lim JP, Bay BH. miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. Int J Oncol. 2016;49:2629\u201336.","journal-title":"Int J Oncol"},{"key":"225_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00432-017-2561-9","volume":"144","author":"C Lv","year":"2018","unstructured":"Lv C, Wang H, Tong Y, et al. The function of BTG3 in colorectal cancer cells and its possible signaling pathway. J Cancer Res Clin Oncol. 2018;144:295\u2013308.","journal-title":"J Cancer Res Clin Oncol"},{"key":"225_CR40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1159\/000485650","volume":"44","author":"K Wei","year":"2017","unstructured":"Wei K, Pan C, Yao G, et al. MiR-106b-5p promotes proliferation and inhibits apoptosis by regulating BTG3 in non-small cell lung cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2017; 44:1545\u201358.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"225_CR41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1349-7006.2001.tb01135.x","volume":"92","author":"Y Yoshida","year":"2001","unstructured":"Yoshida Y, Hosoda E, Nakamura T, Yamamoto T. Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex. Jpn J Cancer Res. 2001;92:592\u20136.","journal-title":"Jpn J Cancer Res"},{"key":"225_CR42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1359-6446(01)01752-4","volume":"6","author":"HD Foda","year":"2001","unstructured":"Foda HD, Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today. 2001;6:478\u201382.","journal-title":"Drug Discov Today"},{"key":"225_CR43","first-page":"1327","volume":"59","author":"Y Sugiura","year":"1999","unstructured":"Sugiura Y, Ma L, Sun B, et al. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis. Cancer Res. 1999;59:1327\u201336.","journal-title":"Cancer Res"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-018-00225-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-018-00225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-018-00225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:45:15Z","timestamp":1606261515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-018-00225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1007\/s13577-018-00225-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"4 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}